Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, October 2008, p. 1616-1622, Vol. 15, No. 10
1071-412X/08/$08.00+0 doi:10.1128/CVI.00185-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
University of Texas School of Public Health,1 Departments of Immunology,2 Pathology, Baylor College of Medicine, Houston, Texas3
Received 23 May 2008/ Returned for modification 27 June 2008/ Accepted 13 August 2008
Children and immunocompromised adults are at an increased risk of tuberculosis (TB), but diagnosis is more challenging. Recently developed gamma interferon (IFN-
) release assays provide increased sensitivity and specificity for diagnosis of latent TB, but their use is not FDA approved in immunocompromised or pediatric populations. Both populations have reduced numbers of T cells, which are major producers of IFN-
. Interleukin 7 (IL-7), a survival cytokine, stabilizes IFN-
message and increases protein production. IL-7 was added to antigen-stimulated lymphocytes to improve IFN-
responses as measured by enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot (ELISPOT) assay. Antigens used were tetanus toxoid (n = 10), p24 (from human immunodeficiency virus [HIV], n = 9), and TB peptides (n = 15). Keyhole limpet hemocyanin was used as a negative control, and phytohemagglutinin was the positive control. IL-7 improved antigen-specific responses to all antigens tested including tetanus toxoid, HIV type 1 p24, and TB peptides (ESAT-6 and CFP-10) with up to a 14-fold increase (mean = 3.8), as measured by ELISA. Increased IFN-
responses from controls, HIV-positive patients, and TB patients were statistically significant, with P values of <0.05, 0.01, and 0.05, respectively. ELISPOT assay results confirmed ELISA findings (P values of <0.01, 0.02, and 0.03, respectively), with a strong correlation between the two tests (R2 = 0.82 to 0.99). Based on average background levels, IL-7 increased detection of IFN-
by 39% compared to the level with antigen alone. Increased production of IFN-
induced by IL-7 improves sensitivity of ELISA and ELISPOT assays for all antigens tested. Further enhancement of IFN-
-based assays might improve TB diagnosis in those populations at highest risk for TB.
Published ahead of print on 27 August 2008.
Supplemental material for this article may be found at http://cvi.asm.org/.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»